At DeciBio Consulting, our mission is to provide market intelligence and insights to advance precision medicine. To this end, we track this space closely, especially the field of precision oncology,
The SARS-CoV-2 DxBook launched in April, during the first few weeks of widespread lockdowns, and the team has diligently collected data on testing behaviors at hospitals around the country
Avoid blind spots in your market. Get the insights you need to accelerate innovation.